TrialClinical drug investigation2016

Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus.

Xiaolan Yong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.